Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myelodysplastic Syndromes × Docetaxel × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 112 Breast Neoplasms 111 Prostatic Neoplasms 79 Lung Neoplasms 37 Neoplasms 27 Squamous Cell Carcinoma of Head and Neck 26 Neoplasm Metastasis 25 Stomach Neoplasms 22 Esophageal Neoplasms 20 Head and Neck Neoplasms 19 Pancreatic Neoplasms 16 Ovarian Neoplasms 15 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Urinary Bladder Neoplasms 12 Sarcoma 10 Triple Negative Breast Neoplasms 8 Carcinoma, Transitional Cell 8 Fallopian Tube Neoplasms 7 Carcinoma, Ovarian Epithelial 7 Adenocarcinoma of Lung 7 Adenocarcinoma Of Esophagus 7 Recurrence 6 Carcinoma, Squamous Cell 5 Carcinoma 5 Inflammatory Breast Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Breast Neoplasms, Male 4 Advanced Solid Tumors 4 Adenocarcinoma 4 Urethral Neoplasms 3

Interventions

fludarabine phosphate 76 Cyclophosphamide 70 Azacitidine 53 Whole-Body Irradiation 51 fludarabine 49 Mycophenolic Acid 46 Busulfan 46 Tacrolimus 42 Melphalan 36 Antilymphocyte Serum 34 Peripheral Blood Stem Cell Transplantation 33 Filgrastim 31 Cytarabine 31 Decitabine 30 Cyclosporine 27 Granulocyte Colony-Stimulating Factor 26 Methotrexate 25 thymoglobulin 21 Thiotepa 20 Cord Blood Stem Cell Transplantation 18 Clofarabine 18 Rituximab 15 Stem Cell Transplantation 14 Sirolimus 13 Lenalidomide 11 Etoposide 11 Alemtuzumab 11 venetoclax 9 Radiotherapy 9 sargramostim 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡